<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15</volume><submitter>Yang M</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Hepatic fibrosis (HF), a progressive chronic liver disease, is a serious threat to global public health. The lack of preventive and therapeutic strategies has created an urgent need for effective anti-fibrosis agents. There is growing evidence that natural products might provide safe and effective interventions for HF. Among them, rhaponticin (RHA), a stilbenoid glucoside natural product isolated from medicinal plants of &lt;i>Rheum&lt;/i> L. of &lt;i>Polygonaceae&lt;/i> Juss. has many pharmacological activities such as anti-inflammatory, antioxidant, antiproliferative, and antithrombotic properties. However, its effects on HF remain unclear.&lt;h4>Methods&lt;/h4>Herein, we investigated the effects of RHA against HF on the carbon tetrachloride (CCl&lt;sub>4&lt;/sub>)-induced hepatic fibrosis </pubmed_abstract><journal>Frontiers in pharmacology</journal><pagination>1505309</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11772292</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Multi-target regulatory effects of rhaponticin in a rat model of hepatic fibrosis revealed by non-targeted metabolomics.</pubmed_title><pmcid>PMC11772292</pmcid><pubmed_authors>Zhang T</pubmed_authors><pubmed_authors>Yang M</pubmed_authors><pubmed_authors>Guo W</pubmed_authors><pubmed_authors>Lin W</pubmed_authors><pubmed_authors>Jiang D</pubmed_authors><pubmed_authors>Huang L</pubmed_authors><pubmed_authors>Peng L</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Zhao J</pubmed_authors><pubmed_authors>Wei Y</pubmed_authors><pubmed_authors>Hao YJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Multi-target regulatory effects of rhaponticin in a rat model of hepatic fibrosis revealed by non-targeted metabolomics.</name><description>&lt;h4>Introduction&lt;/h4>Hepatic fibrosis (HF), a progressive chronic liver disease, is a serious threat to global public health. The lack of preventive and therapeutic strategies has created an urgent need for effective anti-fibrosis agents. There is growing evidence that natural products might provide safe and effective interventions for HF. Among them, rhaponticin (RHA), a stilbenoid glucoside natural product isolated from medicinal plants of &lt;i>Rheum&lt;/i> L. of &lt;i>Polygonaceae&lt;/i> Juss. has many pharmacological activities such as anti-inflammatory, antioxidant, antiproliferative, and antithrombotic properties. However, its effects on HF remain unclear.&lt;h4>Methods&lt;/h4>Herein, we investigated the effects of RHA against HF on the carbon tetrachloride (CCl&lt;sub>4&lt;/sub>)-induced hepatic fibrosis </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024</publication><modification>2025-04-22T10:33:11.933Z</modification><creation>2025-04-22T10:33:11.933Z</creation></dates><accession>S-EPMC11772292</accession><cross_references><pubmed>39877389</pubmed><doi>10.3389/fphar.2024.1505309</doi></cross_references></HashMap>